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1. Introduction
Atherosclerotic cardiovascular disease is still the most common cause of death among adults 
[1]. Its prevalence is increasing in developing countries and despite all advances in both diag-
nostic tools and treatment modalities, it is still very common in the developed world. The 
nutritional and metabolic problems especially obesity, diabetes mellitus, hypercholesterol-
emia and also overuse of dietary salt play a pivotal role in increased cardiovascular morbidity 
and mortality worldwide [1, 2].
The atherosclerotic cardiovascular disease has got a wide clinical spectrum from silent ischemia 
to sudden cardiac death [3]. Myocardial infarction (MI) is at the center of this clinical spectrum, 
and a majority of current clinical efforts are mainly focused on the diagnosis and treatment 
of myocardial infarction. There are still scientific efforts to provide more comprehensive and 
realistic definition for myocardial infarction. The latest expert consensus document including 
experts from the main cardiovascular societies including European Society of Cardiology (ESC), 
American College of Cardiology (ACC), American Heart Association (AHA) and World Heart 
Federation (WHF) established the most comprehensive definition and classification of myocar-
dial infarction to date [4]. Five major types of MI include type 1 MI—MI associated with occlusive 
or nonocclusive athero-thrombotic coronary lesions, type 2 MI—MI associated with mismatch 
between oxygen supply and demand, type 3 MI—MI in patients with ischemia-associated car-
diac death, type 4a, 4b, and 4c—MI associated with percutaneous coronary intervention (PCI), 
and type 5 MI—MI associated with coronary artery bypass grafting surgery [4].
From the very beginning of human life in earth, three major issues including contagious dis-
eases, shortage of food, and wars diminished human population for several years. To date, 
for the first time in history, modern medicine is providing us great success against contagious 
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diseases and advances in agriculture have almost finished the scarcity of food. In our era, 
deaths from over nutrition, obesity, diabetes, and hypercholesterolemia appear to overwhelm 
deaths from shortage of food. Furthermore, increased life expectancy and aging of the popula-
tion have also increased cardiovascular diseases.
The management of ST-segment elevation myocardial infarction (STEMI) is very dynamic and 
several changes are recommended by the current guidelines from 2012 to 2017 [5]. There are 
more evidence to prefer radial access and drug-eluting stents (DESs) in primary preventions. 
Complex revascularizations during primary percutaneous intervention (PCI) were accepted 
as contraindicated (class III indication) in 2012; however, the 2017 guidelines recommend 
complete revascularization during index primary PCI in STEMI patients in shock with class 
IIa indication. Thrombus aspiration is no more recommended during primary PCI according 
to the new guidelines. The use of enoxaparin and early hospital discharge are encouraged in 
the new guidelines (class IIa). Additional lipid lowering therapy is recommended (class IIa) 
if low density lipoprotein levels are over 70 mg/dL despite maximum tolerated statins [5].
Current European revascularization guidelines also recommend radial access as standard 
approach in both angiography and PCI, use of DES instead bare metal stents (BMS) in any 
PCI, use of SYNTAX score in revascularization procedures involving left main coronary 
artery or multivessel disease, use of the same revascularization strategy in patients with non-
STEMI after stabilization of the patient, use of radial artery grafts over saphenous vein grafts 
in patients with severe coronary stenosis, and to prefer CABG surgery for patients with coro-
nary artery disease, heart failure, and left ventricular ejection fraction <35% [6].
In this book, we aimed to provide at the beginning epidemiological data on myocardial infarc-
tion and atherosclerotic cardiovascular disease. Then, in the following chapters, we aimed to 
address the role of current diagnostic biochemical markers in the diagnosis of acute MI. We 
also aimed to overview current management strategies and the role of interventional therapies 
in patients with acute coronary syndromes. At the end of the book, we aimed to provide infor-
mation on “how to manage myocardial infarction in a specific patient group; the children.”
Recent developments in interventional therapies, drugs, and devices lead to important 
decrease in morbidity and mortality from myocardial infarction. Despite all advancements 
in the management of myocardial infarction, morbidity and mortality from atherosclerotic 
cardiovascular diseases and especially myocardial infarction are still high. We think that more 
glory can be achieved by the prevention of atherosclerotic processes, and efforts should be 
focused on the early stages of the disease since it may be very late for some of the patients 
experiencing myocardial infarction.
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